Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Coeptis Therapeutics Holdings Inc COEP

Alternate Symbol(s):  COEPW

Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio and rights are licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform; and DVX201, a clinical-stage, natural killer cell therapy... see more

Current News (NDAQ:COEP)

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates BFIN, COEP, ARIS, CIO on Behalf of Shareholders

GlobeNewswire October 7, 2025

ACT NOW: The M&A Class Action Firm Continues to Investigate the Merger - BFIN, ARIS, CIO and COEP

GlobeNewswire October 7, 2025

Vanderbilt Report: Coeptis Shows How Biotech Can Fund Itself While Innovating

GlobeNewswire September 23, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYBR, UNP, COEP on Behalf of Shareholders

PR Newswire August 28, 2025

Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd

GlobeNewswire July 22, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, COEP, AVDX on Behalf of Shareholders

GlobeNewswire July 5, 2025

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: COEP, RHE, PPBI, and PORT

PR Newswire July 3, 2025

Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared

GlobeNewswire June 26, 2025

Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology

GlobeNewswire May 28, 2025

Opinion & Analysis (NDAQ:COEP)

No current opinion is available.

Bullboard Posts (NDAQ:COEP)

$COEP -#COEPTIS The integration of AI-driven tools

$COEP -#COEPTIS The integration of AI-driven tools, particularly from our recent acquisition of the NexGenAI Affiliates Network...
MasterJediJazz2 - March 25, 2025

$COEP $11.61 +6.51% #nasdaq Coeptis Therapeutics Announces

$COEP $11.61 +6.51% #nasdaq Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform https...
MasterJediJazz2 - March 11, 2025

$COEP $BURU Partnership news: NUBURU, Inc. and COEPTIS

$COEP $BURU Partnership news:  NUBURU, Inc. and COEPTIS (NexGenAI Affiliates Network) announce strategic partnership on artificial...
MasterJediJazz2 - March 6, 2025

$COEP announces another milestone in joining $700B global AI

$COEP announces another milestone in joining the $700B+ global AI Market. https://nasdaq.com/press-release/coeptis-announces-launch...
MasterJediJazz2 - February 20, 2025

$COEP Update out on COEP Venture group

$COEP Update out! "Last week, COEPTIS introduced you to the launch of the COEP Venture Group which will be investing in AI, RPA &...
MasterJediJazz2 - February 19, 2025

$COEP COEPTIS is embarking on an exciting journey

$COEP COEPTIS is embarking on an exciting journey at the intersection of artificial intelligence and blockchain technology! ...
MasterJediJazz2 - February 19, 2025